A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


October 4, 2012

Meningitis Vaccine Now Recommended for Certain HIV+ Gay Men in NYC

The meningococcal vaccine is now being recommended for New York City-residing HIV-positive men who have had intimate contact with other men under certain circumstances, according to a new alert from the NYC Department of Health and Mental Hygiene (DOHMH). The recommendation, issued October 4 by the agency, stems from the recent increase in invasive meningococcal disease cases among men who have sex with men (MSM) and its high fatality rate among those living with HIV.

An investigation into the outbreak was announced September 26, 2012. Since 2010, there have been 13 cases of Neisseria meningitidis—the bacterium responsible for the disease, which causes high fever, headache, stiff neck, and rash and may lead to life-threatening meningitis and pneumonia—among MSM residing in four of the five boroughs of the city. There was one case in 2010, four in 2011 and eight in 2012 (four in the last five weeks).

All cases were men between 21 and 59 years of age and eight are HIV positive. Four patient s have died, three of whom were infected with HIV.

It is important to note that the outbreak of invasive meningococcal disease among MSM in NYC is completely unrelated to the outbreak of fungal-related meningitis in several states that has been tied to the use of an injectable corticosteroid.

Based on the recent invasive meningococcal disease cases in NYC, the DOHMH is recommending the meningococcal vaccine for MSM meeting certain criteria:

1) They are living with HIV, and
2)  they’ve had intimate contact with men they met through an website, a smart phone “app” (e.g., Grindr), or at a bar or party since September 1, 2012.
“Individuals who meet some but not all of these criteria are advised to discuss their need for meningococcal vaccine with their physician or medical provider,” the NYC DOHMH statement clarifies.

There are several meningococcal vaccines licensed for use in adults. The vaccine may provide protection seven to ten days after vaccination, but not everyone will develop protective levels of antibodies.

MSM living with HIV who do receive one dose of the vaccine should return to their health care providers eight weeks later for a necessary second dose.

Because the vaccine is best given in the context of regular medical care for HIV infection, people should first check with their regular health care provider to ask if they have the vaccine. If the medical provider does not have the vaccine, people should visit an HIV clinic where the vaccine is available.

NYC residents may call “311” to find their nearest HIV clinic providing the vaccine.

To read the NYC DOHMH alert, click here.

Search: vaccine, meningococcal, meningitis, new york city, hiv, men who have sex with men, msm, gay, bisexual, department of health

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter

Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.